Butterfly Network (BFLY) vs Neogen (NEOG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Butterfly Network (BFLY) has outperformed Neogen (NEOG) over the past year, gaining 230.8% versus a gain of 108.9%. Over five years, BFLY leads with a -22.3% price change compared with -71.5% for NEOG. Neogen is the larger company by market cap ($2.55 billion vs $2.20 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFLY | NEOG |
|---|---|---|
| Share price | $8.27 | $11.68 |
| Market cap | $2.20B | $2.55B |
| 1-day change | -4.94% | -2.34% |
| YTD return | +117.63% | +67.10% |
| 1-year return | +230.80% | +108.94% |
| 5-year return | -22.27% | -71.54% |
| Forward P/E | — | 30.74 |
| EPS (TTM) | $-0.29 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $870.40M |
| Revenue growth (YoY) | — | -2.72% |
| Net income (latest FY) | — | $-7.90M |
| Gross margin | — | 46.93% |
| Operating margin | — | -2.48% |
| Net margin | — | -0.91% |
| 52-week high | $10.21 | $14.26 |
| 52-week low | $1.90 | $5.37 |
| Distance from 52-week high | -19.00% | -18.09% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +37.85% | +19.86% |
| Average volume | 6.27M | 3.02M |
| Shares outstanding | 244.86M | 218.11M |
| Employees | 220 | 2,636 |
| Sector | Health Care | Health Care |
| Industry | Medical Electronics | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BFLY has outperformed NEOG by 121.9 percentage points over the past year.
About Butterfly Network
BFLY stock →Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.
Health Care · Medical Electronics · 220 employees
About Neogen
NEOG stock →Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 2,636 employees
BFLY vs NEOG FAQ
Which is bigger, Butterfly Network or Neogen?
Neogen (NEOG) is larger, with a market capitalization of $2.55B compared with $2.20B for Butterfly Network (BFLY).
Which stock has performed better over the past year, BFLY or NEOG?
BFLY returned +230.80% over the past 12 months, compared with +108.94% for NEOG (price return, excluding dividends). Past performance does not predict future results.
Are Butterfly Network and Neogen in the same industry?
Both are in the Health Care sector, but in different industries: Medical Electronics for Butterfly Network and Biotechnology: In Vitro & In Vivo Diagnostic Substances for Neogen.